Hicks Anna U, Lappalainen Riikka S, Narkilahti Susanna, Suuronen Riitta, Corbett Dale, Sivenius Juhani, Hovatta Outi, Jolkkonen Jukka
Department of Neurology, University of Kuopio, Kuopio, Finland.
Eur J Neurosci. 2009 Feb;29(3):562-74. doi: 10.1111/j.1460-9568.2008.06599.x. Epub 2009 Jan 17.
Cortical stem cell transplantation may help replace lost brain cells after stroke and improve the functional outcome. In this study, we transplanted human embryonic stem cell (hESC)-derived neural precursor cells (hNPCs) or vehicle into the cortex of rats after permanent distal middle cerebral artery occlusion (dMCAO) or sham-operation, and followed functional recovery in the cylinder and staircase tests. The hNPCs were examined prior to transplantation, and they expressed neuroectodermal markers but not markers for undifferentiated hESCs or non-neural cells. The rats were housed in either enriched environment or standard cages to examine the effects of additive rehabilitative therapy. In the behavioral tests dMCAO groups showed significant impairments compared with sham group before transplantation. Vehicle groups remained significantly impaired in the cylinder test 1 and 2 months after vehicle injection, whereas hNPC transplanted groups did not differ from the sham group. Rehabilitation or hNPC transplantation had no effect on reaching ability measured in the staircase test, and no differences were found in the cortical infarct volumes. After 2 months we measured cell survival and differentiation in vivo using stereology and confocal microscopy. Housing had no effect on cell survival or differentiation. The majority of the transplanted hNPCs were positive for the neural precursor marker nestin. A portion of transplanted cells expressed neuronal markers 2 months after transplantation, whereas only a few cells co-localized with astroglial or oligodendrocyte markers. In conclusion, hESC-derived neural precursor transplants provided some improvement in sensorimotor function after dMCAO, but did not restore more complicated sensorimotor functions.
皮质干细胞移植可能有助于在中风后替代丢失的脑细胞并改善功能结局。在本研究中,我们在大鼠永久性大脑中动脉远端闭塞(dMCAO)或假手术后,将人胚胎干细胞(hESC)来源的神经前体细胞(hNPCs)或赋形剂移植到大鼠皮质中,并在圆柱体和阶梯试验中跟踪功能恢复情况。在移植前对hNPCs进行了检查,它们表达神经外胚层标记物,但不表达未分化的hESCs或非神经细胞的标记物。将大鼠饲养在丰富环境或标准笼中,以检查附加康复治疗的效果。在行为测试中,dMCAO组在移植前与假手术组相比表现出明显的损伤。赋形剂组在注射赋形剂后1个月和2个月的圆柱体试验中仍有明显损伤,而hNPC移植组与假手术组没有差异。康复或hNPC移植对阶梯试验中测量的抓握能力没有影响,皮质梗死体积也没有差异。2个月后,我们使用体视学和共聚焦显微镜在体内测量细胞存活和分化情况。饲养环境对细胞存活或分化没有影响。大多数移植的hNPCs对神经前体标记物巢蛋白呈阳性。一部分移植细胞在移植后2个月表达神经元标记物,而只有少数细胞与星形胶质细胞或少突胶质细胞标记物共定位。总之,hESC来源的神经前体细胞移植在dMCAO后对感觉运动功能有一定改善,但并未恢复更复杂的感觉运动功能。